Bruker, a firm that manufactures scientific instruments and diagnostic tests, led a €14m ($15m) Series B funding round in PreOmics, a developer of a protein analysis platform, with participation from High-Tech Gründerfonds and Think.Health Ventures. “We are excited to increase R&D, marketing and sales investments, and are pleased to have Bruker as a collaborator and major investor. Bruker shares our vision for advanced proteomic discovery processes for everyone, and a commitment to accelerate PreOmics’ growth. Our existing and future customers and partners will benefit from accelerated investments at PreOmics and from proteomics solution synergies to extend our product offerings and global presence," Garwin Pichler, PreOmics Co-Founder and Managing Director.